Trial Profile
A Dose Block-randomized, Double-blind, Placebo-controlled, Single Dosing, Dose-escalation Phase I Clinical Trial to Evaluate the Tolerability, Safety, and Pharmacokinetics of ISU302 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jun 2014
Price :
$35
*
At a glance
- Drugs Imiglucerase (Primary)
- Indications Gaucher's disease
- Focus Adverse reactions
- Sponsors ISU Abxis
- 16 Jun 2014 New trial record